Timedora

Short-Acting β₂-Agonists in Acute Exacerbations

How short-acting β₂-agonists relieve acute airflow obstruction, how they are administered, and how to monitor their effects and risks.

Rapid Bronchodilation: Use and Monitoring

Why these medicines are used

During an acute asthma or COPD exacerbation, airflow can worsen as airway smooth muscle tightens. Short-acting β₂-agonists—such as albuterol (salbutamol) and levalbuterol—are inhaled bronchodilators used for rapid relief. They are first-line relievers in acute asthma and initial bronchodilators in COPD exacerbations.

These medicines stimulate β₂-adrenergic receptors in airway smooth muscle. Stimulation increases cyclic AMP, which relaxes the muscle. As bronchospasm eases, airflow improves and wheezing and breathlessness can lessen.

Choosing a delivery method and checking response

A pressurized metered-dose inhaler (pMDI), preferably used with a spacer, or a nebulizer can deliver the medicine. A nebulizer may be useful when a patient cannot use an inhaler effectively. The choice of delivery method should therefore account for the patient’s ability to use the inhaler.

Treatment requires repeated assessment: check symptom relief, respiratory rate, work of breathing and oxygen saturation. When feasible, also assess or . These observations help show whether the patient is improving; worsening or failure to improve calls for reassessment and escalation of care.

Match monitoring to dose-related risks

Tremor, nervousness, palpitations and a fast heart rate (tachycardia) are common dose-related effects. Repeated high doses can lower serum potassium (hypokalemia) and may contribute to arrhythmias. High-dose treatment can also raise lactate. Thus, when treatment is frequent or high-dose, assess heart rate and consider an ECG and potassium measurement. Consider checking lactate if unexplained acidosis or persistent rapid breathing occurs. These checks complement—not replace—reassessment of breathing and treatment response.

  • : A medicine that stimulates β₂-adrenergic receptors in airway smooth muscle.